Nonsteroidal antiinflammatory drugs and breast cancer

Epidemiology

Volumn 7, Issue 2, 1996, Pages 203-205

  Harris, Randall E ^a,b   Namboodiri, Kadambari K ^a   Farrar, William B ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

aspirin; breast cancer; ibuprofen; nonsteroidal antiinflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0030025365     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-199603000-00017     Document Type: Article

References (11)

1. Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fetal colon cancer. N Engl J Med 1991;325:1593-1596.
2. Reddy BS, Nayini J, Tokumo K, Rigotty J, Zang E, Kelloff G. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with DL-α-difluoromethylornithine, and ornithine decarboxylase inhibitor, in diet. Cancer Res 1990;50:2562-2568.
3. McCormick DL, Madigan MJ, Moon RC. Modulation of rat mammary carcinogenesis by indomethacin. Cancer Res 1985;45:1803-1808.
4. Schlesselman JJ. Case-Control Studies, Design, Conduct, Analysis. New York: Oxford University Press, 1982.
5. Harris RE, Namboodiri KK, Stellman SD, Wynder EL. Nonsteroidal anti-inflammatory drugs and breast cancer risk: heterogeneity of effect in a case-control study. Prev Med 1995;24:119-120.
6. Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994;5:138-146.
7. Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami H-O, Hackler DG, Hoover R, Fraumeni JF Jr. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993;85:307-311.
8. Friedman GD, Ury HK. Initial screening of carcinogenicity of commonly used drugs. J Natl Cancer Inst 1980;65:723-733.
9. Marnett LJ. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 1992;52:5575-5589.
10. Van Aswegen C, van Schalkwyk ICD, Roux LJ, Becker PJ, Du Plessis DJ. A novel study on the effect of acetylsalicylic acid on the binding capacity of estrogen receptors from MCF-7 cells. Clin Physiol Biochem 1992;9:145-149.
11. Kopp E, Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 1994;265:956-959.